129 filings
ARS
2023 FY
IGMS
IGM Biosciences Inc
26 Apr 24
Annual report to shareholders
4:10pm
DEFA14A
IGMS
IGM Biosciences Inc
26 Apr 24
Additional proxy soliciting materials
4:08pm
DEF 14A
IGMS
IGM Biosciences Inc
Definitive proxy
26 Apr 24
4:05pm
8-K
IGMS
IGM Biosciences Inc
17 Apr 24
IGM Biosciences Announces Refocusing of Sanofi Collaboration
8:34am
PRE 14A
IGMS
IGM Biosciences Inc
Preliminary proxy
15 Apr 24
9:01am
S-8
joxd4t9ur8
7 Mar 24
Registration of securities for employees
4:27pm
8-K
d6q byaci0gank041w
7 Mar 24
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
4:10pm
8-K
loe7gfd9 xmiv9hf
8 Jan 24
Results of Operations and Financial Condition
9:00am
8-K
nmpz69k6g
8 Dec 23
IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension
4:05pm
EFFECT
egh9f f9vew5b
28 Nov 23
Notice of effectiveness
12:15am
CORRESP
k112g
15 Nov 23
Correspondence with SEC
12:00am
UPLOAD
l4hd w4fn
14 Nov 23
Letter from SEC
12:00am
8-K
w217q58u xbaw9ydkn1
13 Nov 23
IGM Biosciences Announces Third Quarter 2023 Financial Results
4:10pm
8-K
0uy8hju6wli fyd
3 Oct 23
Departure of Directors or Certain Officers
4:14pm
8-K
1jfwyn5ub8rop
3 Aug 23
IGM Biosciences Announces Second Quarter 2023 Financial Results
4:13pm
D
8afbafejq60e0 v5e7ca
7 Jul 23
Exempt offering of security
2:26pm